Loss of muscleblind-like 1 results in cardiac pathology and persistence of embryonic splice isoforms
- PMID: 25761764
- PMCID: PMC4356957
- DOI: 10.1038/srep09042
Loss of muscleblind-like 1 results in cardiac pathology and persistence of embryonic splice isoforms
Abstract
Cardiac dysfunction is a prominent cause of mortality in myotonic dystrophy I (DM1), a disease where expanded CUG repeats bind and disable the muscleblind-like family of splice regulators. Deletion of muscleblind-like 1 (Mbnl1(ΔE2/ΔE2)) in 129 sv mice results in QRS, QTc widening, bundle block and STc narrowing at 2-4 months of age. With time, cardiac function deteriorates further and at 6 months, decreased R wave amplitudes, sinus node dysfunction, cardiac hypertrophy, interstitial fibrosis, multi-focal myocardial fiber death and calcification manifest. Sudden death, where no end point illness is overt, is observed at a median age of 6.5 and 4.8 months in ~67% and ~86% of male and female Mbnl1(ΔE2/ΔE2) mice, respectively. Mbnl1 depletion results in the persistence of embryonic splice isoforms in a network of cardiac RNAs, some of which have been previously implicated in DM1, regulating sodium and calcium currents, Scn5a, Junctin, Junctate, Atp2a1, Atp11a, Cacna1s, Ryr2, intra and inter cellular transport, Clta, Stx2, Tjp1, cell survival, Capn3, Sirt2, Csda, sarcomere and cytoskeleton organization and function, Trim55, Mapt, Pdlim3, Pdlim5, Sorbs1, Sorbs2, Fhod1, Spag9 and structural components of the sarcomere, Myom1, Tnnt2, Zasp. Thus this study supports a key role for Mbnl1 loss in the initiation of DM1 cardiac disease.
Figures
Similar articles
-
Muscleblind-Like 1 and Muscleblind-Like 3 Depletion Synergistically Enhances Myotonia by Altering Clc-1 RNA Translation.EBioMedicine. 2015 Jul 31;2(9):1034-47. doi: 10.1016/j.ebiom.2015.07.028. eCollection 2015 Sep. EBioMedicine. 2015. PMID: 26501102 Free PMC article.
-
Muscleblind-like 3 deficit results in a spectrum of age-associated pathologies observed in myotonic dystrophy.Sci Rep. 2016 Aug 3;6:30999. doi: 10.1038/srep30999. Sci Rep. 2016. PMID: 27484195 Free PMC article.
-
The Muscleblind family of proteins: an emerging class of regulators of developmentally programmed alternative splicing.Differentiation. 2006 Mar;74(2-3):65-80. doi: 10.1111/j.1432-0436.2006.00060.x. Differentiation. 2006. PMID: 16533306 Review.
-
Colocalization of muscleblind with RNA foci is separable from mis-regulation of alternative splicing in myotonic dystrophy.J Cell Sci. 2005 Jul 1;118(Pt 13):2923-33. doi: 10.1242/jcs.02404. Epub 2005 Jun 16. J Cell Sci. 2005. PMID: 15961406
-
Compound loss of muscleblind-like function in myotonic dystrophy.EMBO Mol Med. 2013 Dec;5(12):1887-900. doi: 10.1002/emmm.201303275. Epub 2013 Oct 8. EMBO Mol Med. 2013. PMID: 24293317 Free PMC article.
Cited by
-
MicroRNA-Based Therapeutic Perspectives in Myotonic Dystrophy.Int J Mol Sci. 2019 Nov 9;20(22):5600. doi: 10.3390/ijms20225600. Int J Mol Sci. 2019. PMID: 31717488 Free PMC article. Review.
-
Molecular characterization of myotonic dystrophy fibroblast cell lines for use in small molecule screening.iScience. 2022 Apr 4;25(5):104198. doi: 10.1016/j.isci.2022.104198. eCollection 2022 May 20. iScience. 2022. PMID: 35479399 Free PMC article.
-
PRMT1 Deficiency in Mouse Juvenile Heart Induces Dilated Cardiomyopathy and Reveals Cryptic Alternative Splicing Products.iScience. 2018 Oct 26;8:200-213. doi: 10.1016/j.isci.2018.09.023. Epub 2018 Oct 2. iScience. 2018. PMID: 30321814 Free PMC article.
-
BEX1 is an RNA-dependent mediator of cardiomyopathy.Nat Commun. 2017 Nov 30;8(1):1875. doi: 10.1038/s41467-017-02005-1. Nat Commun. 2017. PMID: 29192139 Free PMC article.
-
RBPMS2 Is a Myocardial-Enriched Splicing Regulator Required for Cardiac Function.Circ Res. 2022 Dec 2;131(12):980-1000. doi: 10.1161/CIRCRESAHA.122.321728. Epub 2022 Nov 11. Circ Res. 2022. PMID: 36367103 Free PMC article.
References
-
- Harper P. S. Myotonic Dystrophy third edn. (W.B.Saunder, London, 2001).
-
- Phillips M. F. et al. Cardiac disease in myotonic dystrophy. Cardiovasc. Res. 33, 13–22 (1997). - PubMed
-
- Hawley R. J. et al. Myotonic heart disease: a clinical follow-up. Neurology 41, 259–262 (1991). - PubMed
-
- Fragola P. V. et al. Cardiac involvement in myotonic dystrophy. Am. J. Cardiol. 74, 1070–1072 (1994). - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous
